Quest Diagnostics (DGX) Revenue — Quarter Ended Dec 31, 2024
Revenue for the most recent quarter increased compared to both the preceding quarter and the same quarter a year earlier. The company's trailing twelve-month revenue also rose.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue for the most recent quarter increased compared to both the preceding quarter and the same quarter a year earlier. The company's trailing twelve-month revenue also rose.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.6B
Revenue reported for this quarter.
Quarter-over-quarter
+5.3%
Change from the immediately preceding quarter.
Year-over-year
+14.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$9.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $2.4B | +1.5% |
| Jun 30, 2024 | $2.4B | +2.5% |
| Sep 30, 2024 | $2.5B | +8.4% |
| Dec 31, 2024 | $2.6B | +14.6% |
Revenue performance
The reported revenue moved upward, reflecting a positive direction for the quarter.
Quarterly comparison
When compared to the immediately preceding quarter, revenue was higher. The increase relative to the same quarter one year ago was also substantial.
What to watch
The company's cash used for investing activities grew significantly, primarily due to business acquisitions.